Tourbillon Capital Partners’s Insmed INSM Stock Holding History

Tourbillon Capital Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-530,263	Closed	-$9.62M	–	78
2015 Q4	$9.62M	Sell	530,263 -44,799	-8%	-$789K	0.22%	60
2015 Q3	$10.7M	Sell	575,062 -124,938	-18%	-$3.12M	0.28%	70
2015 Q2	$17.1M	Sell	700,000 -550,000	-44%	-$12.5M	0.37%	70
2015 Q1	$26M	Sell	1,250,000 -250,000	-17%	-$4.4M	0.67%	43
2014 Q4	$23.2M	Sell	1,500,000 -26,343	-2%	-$374K	0.63%	47
2014 Q3	$19.9M	Buy	1,526,343 +501,343	+49%	+$7.56M	0.73%	39
2014 Q2	$20.5M	Buy	1,025,000 +325,000	+46%	+$4.81M	1.18%	27
2014 Q1	$13.3M	Buy	700,000 +275,000	+65%	+$5.23M	0.62%	40
2013 Q4	$7.22M	Buy	+425,000	New	+$6.51M	0.62%	51

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tourbillon Capital Partners's INSM Position: Q1 2016 in Review

Tourbillon Capital Partners sold out of Insmed (INSM) in Q1 2016, closing a stake of 530,263 shares — an estimated $9.62M sold.

Tourbillon Capital Partners first reported a position in INSM in Q4 2013 and held it in 9 quarters. The position peaked at $26M in Q1 2015. 101 funds tracked by Wall St. Rank hold INSM as of Q1 2016.

Tourbillon Capital Partners reported no remaining Insmed position as of Q1 2016 after selling out during the quarter.
Tourbillon Capital Partners sold 530,263 Insmed shares in Q1 2016, an estimated $9.62M.
Tourbillon Capital Partners first reported a position in Insmed in Q4 2013 and held it in 9 quarters.
Tourbillon Capital Partners's Insmed position peaked at $26M in Q1 2015.
101 funds tracked by Wall St. Rank held Insmed as of Q1 2016.

Based on Tourbillon Capital Partners's 13F filing for Q1 2016, filed 16 May 2016.